Kanabo Group PLC Partnership to launch a Walk-In Pain Clinic (6124Z)

TIDMKNB

RNS Number : 6124Z

Kanabo Group PLC

15 January 2024

15 January 2024

Kanabo Group Plc

("Kanabo", the "Group" or the "Company")

Partnership with City Dock Pharmacy to launch a Walk-In Pain Clinic

UK's first walk-in clinic for pain management delivering specialised medicine, including medicinal cannabis

Kanabo Group plc (LSE: KNB), the patient-focused provider of digital health services and specialist medicines, including medicinal cannabis, is pleased to announce it has signed a partnership with City Dock Pharmacy in London, to launch a walk-in pain clinic offering specialised medicines, including medicinal cannabis, which is the first of its kind.

The pain clinic, which will be based at City Dock Pharmacy in Wapping, London, will offer both appointment-based and walk-in services. The clinic will leverage Kanabo's Treat It online platform, and pharmacists will be on hand to guide patients through the medicinal cannabis treatment options. Furthermore, the clinic supports the delivery of personalised treatment plans for the growing number of chronic pain sufferers in the UK, who often face difficulties accessing medical treatments due to long waiting times, bureaucracy and affordability.

The partnership with City Dock Pharmacy will combine Kanabo's expertise in medicinal cannabis with traditional treatments for pain management and will cater for patients who are eligible for alternative therapies, as traditional treatments have not delivered improvements. The partnership with City Dock Pharmacy should result in an increase of patients who receive treatment through Kanabo's Treat It platform.

The launch of the walk-in pain clinic with City Dock Pharmacy represents progress against the Group's strategy, as announced on 29 September 2023, to extend its reach into physical pharmacies across the UK offering Kanabo's services to patients. The Company will seek to replicate this model across more pharmacies, leveraging the extensive pharmacy network partnership in Kanabo's digital health division.

Avihu Tamir, Chief Executive Officer of Kanabo, commented:

"This collaboration is a testament to our dedication to innovating in pain management. The combination of City Dock Pharmacy's trusted presence and our expertise in medicinal cannabis paves the way for a new, holistic approach to treating pain and the opportunity to extend this to additional indications."

Enquiries:

 
                                                           via Vigo Consulting 
    Kanabo Group plc                                        [phone] 
    Avihu Tamir, Chief Executive Officer 
    Assaf Vardimon, Chief Financial Officer 
    Ian Mattioli, Non-Executive Chair of the Board 
  Peterhouse Capital Limited (Financial Adviser 
   and Broker) 
   Eran Zucker / Lucy Williams / Charles Goodfellow        [phone] 
  Vigo Consulting (Financial Public Relations/Investor 
   Relations) 
   Jeremy Garcia / Fiona Hetherington / Verity 
   Snow                                                     [phone] 
   [e-mail]                                 0230 
 

About Kanabo Group plc

Kanabo Group plc (LSE:KNB) is a digital health company committed to transforming patient care through its innovative technology platform and specialised treatment offerings. Since its inception in 2017, Kanabo has been focused on researching, developing, and commercialising regulated medicinal cannabis-derived formulations and therapeutic inhalation devices.

Kanabo's NHS-approved online telehealth platform, The GP Service, provides patients with video consultations, online prescriptions, and primary care services. Leveraging its telehealth capabilities, in February 2023, Kanabo launched Treat It - an online clinic focused on chronic pain management providing patients with secondary care.

With its two complementary business divisions, Kanabo has established itself as an end-to-end digital health provider, offering telehealth consultations, prescriptions, alongside the delivery of tailored treatments.

The Company's partially owned subsidiary, Kanabo Agritec Ltd, is a cultivation consultancy supporting cannabis businesses in developing new farms through infrastructural, research, and product guidance. These farms deliver high-quality raw materials for Kanabo's formulas and product line.

At Kanabo Group Plc, we are dedicated to providing patients with the highest quality medical treatments and more accessible healthcare experiences.

Visit www.kanabogroup.com for more information.

About City Dock Pharmacy

City Dock Pharmacy, based in Wapping, London, is at the cutting edge of innovative healthcare. This patient-focused team bridges the gap between traditional and modern medical treatments, serving both NHS and private patients with advanced healthcare technologies.

The pharmacy has an in-house beauty clinic offering various services such as facials, anti-wrinkle injections, Platelet Rich Plasma (PRP) therapy and dermal fillers.

Complementing these offerings is a Pain Management Clinic, which provides expert advice on medical cannabis and various herbal medications, showcasing its comprehensive approach to health and wellness.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEAPFLFFFLEFA

(END) Dow Jones Newswires

January 15, 2024 02:00 ET (07:00 GMT)